Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 11/20 | 0.96 |
| ▸ | FAAH | O00519 | 5/20 | 0.96 |
| ▸ | CNR1 | P21554 | 3/20 | 0.96 |
| ▸ | CNR2 | P34972 | 1/20 | 0.67 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20599319 | 0.98 | EPHX2 (1.00) | EPHX2FAAHCNR1CNR2 | |
| SCHEMBL28929877 | 0.97 | EPHX2 (0.98) | EPHX2FAAHCNR1CNR2 | |
| SCHEMBL22558582 | 0.93 | EPHX2 (1.00) | EPHX2FAAHCNR1CNR2TRPV1 | |
| SCHEMBL29639613 | 0.93 | EPHX2 (1.00) | EPHX2FAAHCNR1CNR2TRPV1 | |
| SCHEMBL22558561 | 0.93 | EPHX2 (1.00) | EPHX2FAAHCNR1CNR2TRPV1 | |
| SCHEMBL20598982 | 0.91 | EPHX2 (1.00) | EPHX2FAAHCNR1CNR2 | |
| SCHEMBL29639614 | 0.91 | EPHX2 (1.00) | EPHX2FAAHCNR1CNR2 | |
| SCHEMBL22558609 | 0.91 | EPHX2 (1.00) | EPHX2FAAHCNR1CNR2 | |
| SCHEMBL31659466 | 0.91 | EPHX2 (0.96) | EPHX2FAAHCNR1CNR2TRPV1 | |
| SCHEMBL31659445 | 0.91 | EPHX2 (0.96) | EPHX2FAAHCNR1CNR2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113759004-A | Quality evaluation method for establishing maca based on UPLC-UV-Q-TOF MS | 中国中医科学院中药研究所 | 2021-12-07 | — | — | CN | claimed |
| CN-113759004-A | Quality evaluation method for establishing maca based on UPLC-UV-Q-TOF MS | 中国中医科学院中药研究所 | 2021-12-07 | — | — | CN | disclosed |